abstract |
The present invention provides a BTK inhibitor compound, a pharmaceutically acceptable salt, a pharmaceutical composition thereof, and a method for treating an autoimmune disease such as rheumatoid arthritis using these compounds, salts, or compositions. To do. [Selection diagram] None |